Shanab Pharma
DEVisit shop ↗
‹ Back to the journal

Industry insights ·

Proactive measures against medicine shortages in Austria

A look back at measures against medicine shortages in Austria and Europe. An industry article from March 2024.

Shanab Pharma editorial team

Illustrative image for the article “Proactive measures against medicine shortages in Austria”

English translation of the German article. It reflects the status at the publication date stated above; later developments may differ.

In recent months, Europe, including Austria, has been struggling with widespread shortages in the supply of medicines. The Austrian federal government has now decided to take active steps to address this challenge. A package of measures, ranging from the short-term establishment of an active substance stockpile to the medium-term mandatory stockpiling of critical medicinal products by the pharmaceutical industry, is intended to increase security of supply.

In particular, the obligation to keep stocks of around 700 essential medicines, intended to cover four months of demand, is a central element of the strategy. This selection includes painkillers, antibiotics and medicines for chronic diseases, among others, and was determined in close cooperation with experts and stakeholders from the healthcare sector. Federal Minister Johannes Rauch emphasised the importance of these measures, not only to secure the supply of medicines for the coming winter but also to act as a pioneer for a comprehensive European solution.

A further step towards improving the supply situation is the simplification of the magistral preparation of medicines in pharmacies. Increasing the fee for this service by an average of 50 per cent is intended to offset higher staff and production costs. This adjustment, in effect since 1 January 2024, makes it easier for pharmacies to prepare medicines on site and serves as another means of managing acute shortages effectively.

These measures illustrate Austria’s commitment to ensuring the supply of medicines for its population even under difficult conditions. At the same time, they point to the need for a long-term, cross-border solution to strengthen the resilience of the healthcare system at European level.

Source (in German): https://www.sozialministerium.gv.at/Services/Aktuelles/Archiv-2024/arzneimittelbevorratung.html (accessed 15 November 2026)